We describe in vivo selection of a Klebsiella pneumoniae strain with diminished imipenem susceptibility attributable to plasmid-encoded ACC-1 -lactamase production and loss of a 36-kDa major outer membrane protein, together with transfer of this plasmid from K. pneumoniae to Escherichia coli in a Tunisian infant.Resistance to carbapenems in gram-negative bacteria may be due either to carbapenemase production or to combination of chromosomal or plasmid-mediated class C -lactamase overproduction and impermeability (20). Among plasmid-mediated AmpC proteins, only ACT-1 and CMY-2 types have been reported to confer resistance to imipenem in association with porin loss (4,5,12).We isolated a Klebsiella pneumoniae strain with diminished imipenem susceptibility from a Tunisian infant. This resistance was related to a combination of plasmid-mediated AmpC ACC-1 expression and impermeability acquired under antimicrobial pressure.A 1-year-old boy from Tunisia with spina bifida and cloacal extrophy was admitted to Robert-Debré hospital (Paris, France) for reconstruction, enterocystoplasty (Mitrofanoff procedure), and pelvic osteotomy. Surgery was complicated by suppuration and disunion of the pubic symphysis. Pus culture yielded ampicillin-resistant Escherichia coli and ceftazidimeresistant Pseudomonas aeruginosa. Imipenem and amikacin were given for 20 days postoperatively. Before surgery, fecal analysis showed carriage of a cefotaxime-resistant, imipenemsusceptible K. pneumoniae strain (isolate K1, 10 5 CFU/g). At the end of antibacterial chemotherapy (postoperative day 20), the ileal flora grew a cefotaxime-resistant K. pneumoniae strain with diminished imipenem sensitivity (isolate K2, 10 5 CFU/g). The child subsequently developed two urinary tract infections due to an ampicillin-resistant E. coli strain (isolate E1), on postoperative days 30 and day 45, both episodes being treated with cefotaxime and gentamicin. A third culture of the enteric flora on day 45 grew both a cefotaxime-resistant E. coli strain (isolate E2, 10 8 CFU/g) and the previous K. pneumoniae isolate, K2 (10 5 CFU/g). K. pneumoniae and E. coli were identified using commercial kits (API 20E and ID32GN; Biomerieux, Marcy l'Etoile, France). Antimicrobial susceptibility was tested by the disk diffusion method on Mueller-Hinton agar (Sanofi-Diagnostics Pasteur, Marnes-La-Coquette, France), as recommended by the Clinical and Laboratory Standards Institute. The MICs of amoxicillin, cefoxitin, cefotaxime, ceftazidime, cefepime, and imipenem were determined by the E-test method (Biodisk, Solna, Sweden). The imipenem and cefepime MICs were also determined by the E-test method on Mueller-Hinton agar containing 250 g/ml cloxacillin (17).Resistance transfer experiments from E. coli E1 and K. pneumoniae K1 and K2 were performed by conjugation with E. coli J53-2 as previously described (1). The MICs of selected -lactam antibiotics and associated resistance markers for the clinical isolates and transconjugants are shown in Table 1.Clinical isolates E2, K1, and K2 w...